Chemistry: analytical and immunological testing – Biospecific ligand binding assay
Patent
1993-07-12
1994-09-06
Baker, Keith
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
436503, 436504, 436 69, 435 71, 435 78, 435 793, 435 13, G01N 33566
Patent
active
053447832
ABSTRACT:
An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of the PAI in a wide range of snake venom samples were accomplished. The purified PAI from several of these active snake venoms is described. In addition, PAIs lacking the Arg-Gly-Asp adhesion sequence but containing Lys-Gly-Asp are prepared and shown to specifically inhibit the binding of fibrinogen or von Willebrand Factor to GP IIb-IIIa.
REFERENCES:
Nachman et al (1982) J. Clin. Invest 69, 263-269.
Bennett et al (1983) Proc. Natl. Acad. Sci. 80, 2417-2421.
Phillips et al. (1988) Blood 71, 831-843.
Samanen et al., J. Cell. Biol. (1990) Supplement 14A:A229.
Dennis et al., Proc. Natl. Acad. Sci. (1989) 87:2471-2475.
Shebuski et al., J. Biol. Chem. (1989) 264(36):21550-21556.
Ali et al., Peptides: Chemistry, Structure and Biology (Proceedings of the 11th American Peptide Symposium), Marshall, G. R. and River, J. E. editors, EXCOM, Leiden (1990).
Charo Israel F.
Scarborough Robert M.
Baker Keith
COR Therapeutics Inc.
LandOfFree
Platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1329335